The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update-Reference-Cited by-同舟云学术

The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update

Published:2022-02-28 Issue:1 Volume:16 Page:20-30
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Wen Ningyuan¹,Cai Yulong¹,Li Fuyu¹,Ye Hui¹,Tang Wei¹,Song Peipei²,Cheng Nansheng¹

Affiliation:

1. Department of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan, China.

2. Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health (social science)

Link

https://www.jstage.jst.go.jp/article/bst/16/1/16_2022.01061/_pdf

Reference69 articles.

1. 1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018; 69:182-236.

2. 2. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385:117-171.

3. 3. Sommacale D, Rhaiem R, Piardi T, Cagniet A, Kianmanesh R. Comments on "Liver resection using total vascular exclusion of the liver preserving the caval flow, in situ hypothermic portal perfusion and temporary porta-caval shunt: A new technique for central tumors". Hepatobiliary Surg Nutr. 2017; 6:207-209.

4. 4. Song P, Cai Y, Tang H, Li C, Huang J. The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines from 2001 to 2017. Biosci Trends. 2017; 11:389-398.

5. 5. Ferenci P, Fried M, Labrecque D, et al. World Gastroenterology Organisation Guidelines and Publications Committee. World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): A global perspective. J Gastrointestin Liver Dis. 2010; 19:311-317.

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure of POU2AF1 recombinant protein and it affects the progression and treatment of liver cancer based on WGCNA and molecular docking analysis;International Journal of Biological Macromolecules;2024-10

2. Identification of immunosenescence of unconventional T cells in hepatocellular carcinoma;Computational Biology and Chemistry;2024-10

3. Comparison of Gd-EOB-DTPA-enhanced MRI and Contrast-enhanced Ultrasound for measuring tumor size of solitary hepatocellular carcinoma ≤ 5cm: A real-world study;2024-09-11

4. A preformulation study of marine alkaloid aaptamine: Physicochemical properties investigation and liposomal formulation development toward hepatocellular carcinoma treatment;European Journal of Lipid Science and Technology;2024-09-08

5. Development and efficacy evaluation of nanoliposomes targeting CAFs-LCSCs communication for hepatocellular carcinoma treatment;Chemical Engineering Journal;2024-09